During the last session, Tectonic Therapeutic Inc (NASDAQ:TECX)’s traded shares were 0.41 million, with the beta value of the company hitting 1.16. At the end of the trading day, the stock’s price was $46.74, reflecting an intraday gain of 10.76% or $4.54. The 52-week high for the TECX share is $53.41, that puts it down -14.27 from that peak though still a striking 74.07% gain since the share price plummeted to a 52-week low of $12.12. The company’s market capitalization is $689.54M, and the average intraday trading volume over the past 10 days was 0.13 million shares, and the average trade volume was 117.21K shares over the past three months.
Tectonic Therapeutic Inc (TECX) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.00. TECX has a Sell rating from 0 analyst(s) out of 2 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 2 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be 0.
Tectonic Therapeutic Inc (NASDAQ:TECX) trade information
Tectonic Therapeutic Inc (TECX) registered a 10.76% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 10.76% in intraday trading to $46.74, hitting a weekly high. The stock’s 5-day price performance is 11.23%, and it has moved by -1.48% in 30 days. Based on these gigs, the overall price performance for the year is 192.86%. The short interest in Tectonic Therapeutic Inc (NASDAQ:TECX) is 0.57 million shares and it means that shorts have 5.23 day(s) to cover.
Tectonic Therapeutic Inc (TECX) estimates and forecasts
Statistics show that Tectonic Therapeutic Inc has underperformed its competitors in share price, compared to the industry in which it operates. Tectonic Therapeutic Inc (TECX) shares have gone up 174.94% during the last six months, with a year-to-date growth rate less than the industry average at -425.95% against 16.50.
While earnings are projected to return 55.54% in 2025.
TECX Dividends
Tectonic Therapeutic Inc is due to release its next quarterly earnings in February. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Also, the Mutual Funds coming in first place with the largest holdings of Tectonic Therapeutic Inc (TECX) shares are Vanguard Total Stock Market Index Fund and Fidelity Advisor Biotechnology Fund . Data provided on Sep 30, 2024 indicates that Vanguard Total Stock Market Index Fund owns about 381.59 shares. This amounts to just over 2.59 percent of the company’s overall shares, with a $17.84 million market value. The same data shows that the other fund manager holds slightly less at 142.6, or about 0.97% of the stock, which is worth about $6.67 million.
